Back
Atara Biotherapeutics Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Buy
60
ATRA
Atara Biotherapeutics
Last Price:
$15.63
Seasonality Move:
5.9%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
The current trend is moderately bullish and ATRA is experiencing slight buying pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.08 | Buy |
| 20-day SMA: | 12.82 | Buy |
| 50-day SMA: | 11.97 | Buy |
| 200-day SMA: | 11.6 | Buy |
| 8-day EMA: | 15.42 | Buy |
| 20-day EMA: | 13.75 | Buy |
| 50-day EMA: | 12.16 | Buy |
| 200-day EMA: | 14.22 | Buy |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 66.4 | Buy |
| Chaikin Money Flow: | 26265 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.66 - 14.94) | Buy |
| Bollinger Bands (100): | (7.52 - 12.48) | Buy |
Atara Biotherapeutics Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 16.53 while ATRA 8-day simple moving average is 15.08, which is a Buy signal.
-
The stock price of ATRA is 16.53 while Atara Biotherapeutics 20-day SMA is 12.82, which makes it a Buy.
-
Atara Biotherapeutics 50-day simple moving average is 11.97 while ATRA share price is 16.53, making it a Buy technically.
-
ATRA stock price is 16.53 and Atara Biotherapeutics 200-day simple moving average is 11.60, creating a Buy signal.
ATRA Technical Analysis vs Fundamental Analysis
Buy
60
Atara Biotherapeutics (ATRA)
is a Buy
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a BuyThe current Atara Biotherapeutics [ATRA] share price is $16.53. The Score for ATRA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
90M
Price in USD:
16.53
Share Volume:
72.1K
Atara Biotherapeutics 52-Week Range
52-Week High:
39.50
52-Week Low:
6.50
Buy
60
Atara Biotherapeutics (ATRA)
is a Buy
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 16.53 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is not overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 16.53 while ATRA 8-day exponential moving average is 15.42, which is a Buy signal.
-
The stock price of ATRA is 16.53 while Atara Biotherapeutics 20-day EMA is 13.75, which makes it a Buy.
-
Atara Biotherapeutics 50-day exponential moving average is 12.16 while ATRA share price is 16.53, making it a Buy technically.
-
ATRA stock price is 16.53 and Atara Biotherapeutics 200-day simple moving average is 14.22, creating a Buy signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $10.45 per share, and an increase next year of $5.50 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is 1.37, suggesting Atara Biotherapeutics is a Buy
-
Atara Biotherapeutics Relative Strength Index (RSI) is 66.4, which suggest Atara Biotherapeutics is overbought
-
The Bollinger Bands (25) for Atara Biotherapeutics is (10.66 - 14.94), which suggest Atara Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Atara Biotherapeutics is (7.52 - 12.48), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.